These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21935576)

  • 1. Role of autophagy in resistance to oxaliplatin in hepatocellular carcinoma cells.
    Du H; Yang W; Chen L; Shi M; Seewoo V; Wang J; Lin A; Liu Z; Qiu W
    Oncol Rep; 2012 Jan; 27(1):143-50. PubMed ID: 21935576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATG7 deficiency promote apoptotic death induced by Cisplatin in human esophageal squamous cell carcinoma cells.
    Zhu L; Du H; Shi M; Chen Z; Hang J
    Bull Cancer; 2013; 100(7-8):15-21. PubMed ID: 23823853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma.
    Lim SC; Choi JE; Kang HS; Han SI
    Int J Cancer; 2010 Apr; 126(7):1582-95. PubMed ID: 19728331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation.
    Ding ZB; Hui B; Shi YH; Zhou J; Peng YF; Gu CY; Yang H; Shi GM; Ke AW; Wang XY; Song K; Dai Z; Shen YH; Fan J
    Clin Cancer Res; 2011 Oct; 17(19):6229-38. PubMed ID: 21825039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of autophagic flux by salinomycin results in anti-cancer effect in hepatocellular carcinoma cells.
    Klose J; Stankov MV; Kleine M; Ramackers W; Panayotova-Dimitrova D; Jäger MD; Klempnauer J; Winkler M; Bektas H; Behrens GM; Vondran FW
    PLoS One; 2014; 9(5):e95970. PubMed ID: 24816744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelial-mesenchymal transition.
    Li J; Yang B; Zhou Q; Wu Y; Shang D; Guo Y; Song Z; Zheng Q; Xiong J
    Carcinogenesis; 2013 Jun; 34(6):1343-51. PubMed ID: 23430956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M2 tumor-associated macrophages produce interleukin-17 to suppress oxaliplatin-induced apoptosis in hepatocellular carcinoma.
    Guo B; Li L; Guo J; Liu A; Wu J; Wang H; Shi J; Pang D; Cao Q
    Oncotarget; 2017 Jul; 8(27):44465-44476. PubMed ID: 28591705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atg5 siRNA inhibits autophagy and enhances norcantharidin-induced apoptosis in hepatocellular carcinoma.
    Xiong X; Wu M; Zhang H; Li J; Lu B; Guo Y; Zhou T; Guo H; Peng R; Li X; Tian Q; Wang Y
    Int J Oncol; 2015 Oct; 47(4):1321-8. PubMed ID: 26240015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative regulation of transcription factor FoxM1 by p53 enhances oxaliplatin-induced senescence in hepatocellular carcinoma.
    Qu K; Xu X; Liu C; Wu Q; Wei J; Meng F; Zhou L; Wang Z; Lei L; Liu P
    Cancer Lett; 2013 Apr; 331(1):105-14. PubMed ID: 23262037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging role of autophagy during ischemia-hypoxia and reperfusion in hepatocellular carcinoma.
    Du H; Yang W; Chen L; Shen B; Peng C; Li H; Ann DK; Yen Y; Qiu W
    Int J Oncol; 2012 Jun; 40(6):2049-57. PubMed ID: 22469951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulated HOXC8 Expression Is Associated with Poor Prognosis and Oxaliplatin Resistance in Hepatocellular Carcinoma.
    Xu P; Zhang X; Ni W; Fan H; Xu J; Chen Y; Zhu J; Gu X; Yang L; Ni R; Chen B; Shi W
    Dig Dis Sci; 2015 Nov; 60(11):3351-63. PubMed ID: 26123838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMP4 promotes oxaliplatin resistance by an induction of epithelial-mesenchymal transition via MEK1/ERK/ELK1 signaling in hepatocellular carcinoma.
    Ma J; Zeng S; Zhang Y; Deng G; Qu Y; Guo C; Yin L; Han Y; Cai C; Li Y; Wang G; Bonkovsky HL; Shen H
    Cancer Lett; 2017 Dec; 411():117-129. PubMed ID: 28987388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy contributes to the enrichment and survival of colorectal cancer stem cells under oxaliplatin treatment.
    Yang HZ; Ma Y; Zhou Y; Xu LM; Chen XJ; Ding WB; Zou HB
    Cancer Lett; 2015 May; 361(1):128-36. PubMed ID: 25749420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulated DYRK2 expression is associated with poor prognosis and Oxaliplatin resistance in hepatocellular carcinoma.
    Zhang X; Xu P; Ni W; Fan H; Xu J; Chen Y; Huang W; Lu S; Liang L; Liu J; Chen B; Shi W
    Pathol Res Pract; 2016 Mar; 212(3):162-70. PubMed ID: 26804244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sorafenib overcomes the chemoresistance in HBx-expressing hepatocellular carcinoma cells through down-regulation of HBx protein stability and suppresses HBV gene expression.
    Kim HY; Jung HU; Yoo SH; Yoo KS; Cheong J; Park BS; Yun I; Yoo YH
    Cancer Lett; 2014 Dec; 355(1):61-9. PubMed ID: 25218348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD13 Induces Autophagy to Promote Hepatocellular Carcinoma Cell Chemoresistance Through the P38/Hsp27/CREB/ATG7 Pathway.
    Zhao Y; Wu H; Xing X; Ma Y; Ji S; Xu X; Zhao X; Wang S; Jiang W; Fang C; Zhang L; Yan F; Wang X
    J Pharmacol Exp Ther; 2020 Sep; 374(3):512-520. PubMed ID: 32571958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
    Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
    Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells.
    Yang J; Pi C; Wang G
    Biomed Pharmacother; 2018 Jul; 103():699-707. PubMed ID: 29680738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
    He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
    Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.
    Yin X; Tang B; Li JH; Wang Y; Zhang L; Xie XY; Zhang BH; Qiu SJ; Wu WZ; Ren ZG
    J Exp Clin Cancer Res; 2017 Nov; 36(1):166. PubMed ID: 29169374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.